MarketsGlenmark Pharmaceuticals Q1 PAT Down 86% at ₹46.97 Cr Dragged by US Litigation Settlement ProvisionBY PTI
MarketsInfibeam Avenues Posts ₹85 Cr PAT in Q1; Board Clears E-Comm Tech Transfer to Rediff for ₹800 CrBY PTI